Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2021 07:00 ET | Source: Finch Therapeutics Group, Inc.

Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference

SOMERVILLE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
April 27, 2021 07:00 ET | Source: Finch Therapeutics Group, Inc.

Finch Therapeutics Appoints Susan E. Graf to Board of Directors

SOMERVILLE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
April 15, 2021 07:00 ET | Source: Finch Therapeutics Group, Inc.

Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit

SOMERVILLE, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
March 18, 2021 22:32 ET | Source: Finch Therapeutics Group, Inc.

Finch Therapeutics Announces Pricing of Upsized Initial Public Offering

SOMERVILLE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its...